These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36858026)

  • 21. A mode of CVVH with regional citrate anticoagulation compared to no anticoagulation for acute kidney injury patients at high risk of bleeding.
    Gao J; Wang F; Wang Y; Jin D; Tang L; Pan K
    Sci Rep; 2019 Apr; 9(1):6607. PubMed ID: 31036927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.
    Zarbock A; Küllmar M; Kindgen-Milles D; Wempe C; Gerss J; Brandenburger T; Dimski T; Tyczynski B; Jahn M; Mülling N; Mehrländer M; Rosenberger P; Marx G; Simon TP; Jaschinski U; Deetjen P; Putensen C; Schewe JC; Kluge S; Jarczak D; Slowinski T; Bodenstein M; Meybohm P; Wirtz S; Moerer O; Kortgen A; Simon P; Bagshaw SM; Kellum JA; Meersch M;
    JAMA; 2020 Oct; 324(16):1629-1639. PubMed ID: 33095849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complications of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy: An Observational Study.
    Bianchi NA; Altarelli M; Eckert P; Schneider AG
    Blood Purif; 2020; 49(5):567-575. PubMed ID: 32126564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early experience of using regional citrate anticoagulation for continuous renal replacement therapy in critically ill patients in a resource-limited setting.
    Hasan MS; Jamaludin MA; Mohd Azman SA; Atan R; Yap MH; Lee ZY; Mohd Yunos N
    Nephrology (Carlton); 2024 Aug; 29(8):528-536. PubMed ID: 38830816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional Citrate Anticoagulation versus No-Anticoagulation for Continuous Venovenous Hemofiltration in Acute Severe Hypernatremia Patients with Increased Bleeding Risk: A Retrospective Cohort Study.
    Zhao L; Ma F; Yu Y; Li Y; Wang Y; He L; Zhou M; Tian X; Jing R; Li L; Li L; Huang C; Bai M; Sun S
    Blood Purif; 2020; 49(1-2):44-54. PubMed ID: 31522180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticoagulant effect of low concentration plasma trisodium citrate in continuous veno-venous hemofiltration.
    Long J; Li Z; Zhang Z; Dong X; Zhu C
    Ann Palliat Med; 2021 Aug; 10(8):8900-8908. PubMed ID: 34488377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding.
    Palsson R; Niles JL
    Kidney Int; 1999 May; 55(5):1991-7. PubMed ID: 10231464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Safety and efficacy of regional citrate anticoagulation in continuous renal replacement therapy in the presence of acute kidney injury after hepatectomy].
    Zhang C; Lin T; Zhang J; Liang H; Di Y; Li N; Gao J; Wang W; Liu S; Wang Z; Jiang H; Liu C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Aug; 30(8):777-782. PubMed ID: 30220281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional citrate anticoagulation versus low molecular weight heparin for CRRT in hyperlactatemia patients: A retrospective case-control study.
    Li L; Bai M; Zhang W; Zhao L; Yu Y; Sun S
    Int J Artif Organs; 2022 Apr; 45(4):343-350. PubMed ID: 33784842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional Citrate Anticoagulation for Continuous Kidney Replacement Therapy With Calcium-Containing Solutions: A Cohort Study.
    Rhee H; Berenger B; Mehta RL; Macedo E
    Am J Kidney Dis; 2021 Oct; 78(4):550-559.e1. PubMed ID: 33798636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot randomized controlled crossover study comparing regional heparinization to regional citrate anticoagulation for continuous venovenous hemofiltration.
    Fealy N; Baldwin I; Johnstone M; Egi M; Bellomo R
    Int J Artif Organs; 2007 Apr; 30(4):301-7. PubMed ID: 17520566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of regional citrate anticoagulation in continuous veno-venous hemofiltration of severe burn patients].
    Wang ZY; Feng SH; Fan BL; Ma W; Jia XC; Geng H
    Zhonghua Shao Shang Za Zhi; 2021 Dec; 37(12):1137-1142. PubMed ID: 34839601
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunomodulation Effect of Regional Citrate Anticoagulation in Acute Kidney Injury Requiring Renal Replacement Therapy.
    Kaewdoungtien P; Tachaboon S; Kangsumrith N; Srisawat N
    Blood Purif; 2023; 52(5):474-482. PubMed ID: 36917959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium-containing versus calcium-free replacement solution in regional citrate anticoagulation for continuous renal replacement therapy: a randomized controlled trial.
    Wei T; Tang X; Zhang L; Lin L; Li P; Wang F; Fu P
    Chin Med J (Engl); 2022 Oct; 135(20):2478-2487. PubMed ID: 36583864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Citrate anticoagulation in plasma exchange followed by continuous renal replacement therapy in critically ill children.
    Xinping Z; Jie H; Zhenya Y; Desheng Z; Xiong Z
    Int J Artif Organs; 2024 Feb; 47(2):85-95. PubMed ID: 38229209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of citrate in cardiovascular system and clot circuit in critically ill patients requiring continuous renal replacement therapy.
    Trakarnvanich T; Sirivongrangson P; Trongtrakul K; Srisawat N
    J Artif Organs; 2023 Mar; 26(1):53-64. PubMed ID: 35412099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional citrate anticoagulation in predilution continuous venovenous hemofiltration using prismocitrate 10/2 solution.
    Shum HP; Chan KC; Yan WW
    Ther Apher Dial; 2012 Feb; 16(1):81-6. PubMed ID: 22248200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation.
    Khadzhynov D; Schelter C; Lieker I; Mika A; Staeck O; Neumayer HH; Peters H; Slowinski T
    J Crit Care; 2014 Apr; 29(2):265-71. PubMed ID: 24360392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: A meta-analysis of randomized controlled trials.
    Li R; Gao X; Zhou T; Li Y; Wang J; Zhang P
    Ther Apher Dial; 2022 Dec; 26(6):1086-1097. PubMed ID: 35385216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.